biochemistry lab test list

Serum also contains other proteins, but none contributes more than 5% of the total, and most much less. 9/24/13 Benedict Benedict's Test for Reducing Sugars The Benedict's test allows us to detect the presence of reducing sugars (sugars with a free aldehyde or ketone group). Blood chemistry tests are among the most common diagnostic tests performed to detect and diagnose illnesses. Your blood contains many chemicals, not just red and white blood cells.. Sudan III test Procedure: Take 0.5 ml ether or chloroform in a test tube and add 0.5 ml sample—drop by drop […] This chapter discusses the normal and pathologic values for commonly ordered tests of the blood (cells and chemistries), urine, cerebrospinal fluid, and other serous fluids. Chemistry panels are groups of tests that are routinely ordered to determine a person's general health status. For a list of the tests included in each of these panels and more information, such as when they may be ordered, click on the name of the panel above to go to its full article. High total protein in the blood is not a specific disease or condition, but it may indicate some problems in the body. from any legal claims, rights, or causes of action you may have in connection with the responses provided to the questions that you submit to the Service. reducing sugar to form cuprous oxide (Cu2O), a red-brown precipitate. The total protein level in the blood can be elevated (hyperproteinemia), decreased (hypoproteinemia), or normal (normoproteinemia). The final color of the solution depends on how much of this precipitate was amounts of class time, and annoying both your lab partners and your instructor. This website uses cookies to ensure you get the best experience on our website. The normal level of total protein is about 6-8 g/dL (60-83 g/L). Return to Lab 3 Home Page Each Blood chemistry indicates hydration levels, whether or not an infection is present, and … from your use of the information provided by this Service for any reason, including but not limited to any misunderstanding or misinterpretation of the information provided through this Service. Solubility Test for Lipid 3. The laboratory recommends a fasting interval of 10 – 14 hrs when fasting status is required for a test, General Information - Samples and Request Forms, Patient Guides & Specialist Request Forms, 1,25 Dihydroxyvitamin D (1,25 Dihydroxycholecalciferol), Alpha-glucosidase / acid maltase (Pompe) (Blood Spot), Androgen profile (females) - Includes testosterone, SHBG, DHA sulphate and FAI, Angiotensin Converting Enzyme (ACE) (CSF), Cholesterol (total):HDL Cholesterol ratio, Cholinesterase (for poisoning - RBC Cholinesterase), Down's Screen - Combined Test (1st trimester), Down's screen - Quadruple Test (2nd trimester), eGFR (Estimated Glomerular Filtration Rate), Fibrosis 4 (FIB4, FIB 4, FIB-4, Fibrosis-4), Free and Acyl-carnitine profile (Blood Spot), Galactose-1-phosphate uridyl transferase (GalPUT), Glycosaminoglycans (mucopolysaccharides) (Urine), Heterophillic Antibodies (thyroid interference), Immunoreactive Trypsin (IRT) (blood spot), Insulin-like growth factor binding protein (IGFBP1), Insulin-like growth factor binding protein (IGFBP2), Metadrenalines (Metanephrines, biogenic amines), Neurotransmitters (CSF) (Monoamine metabolites), N-Terminal pro-brain natriuretic peptide (NT-proBNP), Protein (urine) 24h collection no longer required - see below, Sugar Chromatography - faeces (reducing substances), Sugar Chromatography - urine (reducing substances), Tau Protein (Beta-2-transferrin, asialotransferrin), Thiopurine metabolites (6-Thioguanine nucleotide and 6-Methylmercaptopurine), Thiopurine Methyltransferase (TPMT) (Azathioprine sensitivity), Total human Chorionic Gonadotrophin (hCG), Urea, creatinine and Electrolytes (urine), Urine Microalbumin:Creatinine Ratio (Albumin:Creatinine Ratio), VMA (Vanillylmandelic acid) (HMMA) + HVA (Homovanillic Acid). all have a free reactive carbonyl group. This form enables patients to ask specific questions about lab tests. Blood consists of a liquid part (plasma) and a solid part (the formed elements) that includes red blood cells (erythrocytes), white blood cells (leukocytes), and platelets. Please check your spelling carefully, and watch for capital letters. © 2018 Dr Lal PathLabs. It is important that you communicate with your physician so that together you can integrate the pertinent information, such as age, ethnicity, health history, signs and symptoms, laboratory and other procedures (radiology, endoscopy, etc. The total protein is an indicator of the protein metabolism of the body, which reflects the total content of all proteins in the blood serum. These values may vary depending on the laboratory, gender, age, and other factors. Lab - Daily routine tests Lab* - Batches POCT – Point of Care Testing REF- Referral to other hospitals including use referral lab’s reference range Note turn around time for tests referred to another hospital is 4 weeks or less unless specifically stated. Now book any diagnostic lab tests in India and view reports online on Dr Lal PathLabs. Most globulins are synthesized in the liver, and others are made by the immune system. Some disaccharides have exposed The Benedict's test allows us to detect the presence of reducing sugars (sugars with Other disaccharides such as All Right Reserved. Benedict's Test for Reducing Sugars Looks like you’ve clipped this slide to already. 2 0 obj They are produced in different places throughout the body and circulate in the blood. It may also be used to monitor diabetes or kidney disease. The laboratory recommends a fasting interval of 10 – 14 hrs when fasting status is required for a test Complete list of All Tests and Profiles for Biochemistry Tests Biochemistry Profile in Refrigerated Serum NHANES 1999–2000 1. Now customize the name of a clipboard to store your clips. The analyses are performed with a Hitachi Model 917 multichannel analyzer (Roche Diagnostics, Indianapolis, IN). sucrose are non-reducing sugars and will not react with Benedict's solution. These values may vary depending on the laboratory, gender, age, and other factors. All monosaccharides are reducing sugars; they all have a free reactive carbonyl group. SUMMARY OF TEST PRINCIPLE AND CLINICAL RELEVANCE . Examples of common chemistry panels include: While most laboratories offer the same set of CMP and BMP tests, some of these other panels may be tailored to meet the needs of the health practitioner ordering the tests. �x|S���~��p��c���e����k���n�+� If you continue browsing the site, you agree to the use of cookies on this website. %���� A-Z list of medical tests from Dr Lal PathLabs. List of biochemical tests 1. Albumin also helps carry bilirubin, hormones, vitamins, and medicines through the blood. Biochemical tests in clinical medicine lect1, DIFFUSION BASED AND VASCULAR CONSTRUCTS, TRANSPORT OF NUTRIENTS AND METABOLITES, No public clipboards found for this slide. Return to Welcome Page The copper sulfate (CuSO4) present in endobj The normal level of total protein is about 6-8 g/dL (60-83 g/L). A total protein test is often included in the "Liver Function Tests". If you wish to opt out, please close your SlideShare account. Return to 170 Course Outline Page 2�"��;�'ɂ�E"d���K2&h�R�T�)ñ�Q����2��2a�����5Fĉ�K���h�U�R�� i+S����`:ܙ�%w��:rbҋT��͌�f�� General Test for Lipid: 1. Biochemistry test refers to the chemical identification of a particular enzyme or protein in bodily fluid samples like blood or urine. The 22 analytes described in this method constitute the routine biochemistry profile. Cu+ Cu2O (precipitate) The biochemistry laboratory course, like all laboratory courses, is an exploration of procedures. Emulsification Test for Lipid. CuSO4 Cu++ + SO4-- %PDF-1.5 <> <>/XObject<>/ProcSet[/PDF/Text/ImageB/ImageC/ImageI] >>/MediaBox[ 0 0 612 792] /Contents 4 0 R/Group<>/Tabs/S/StructParents 0>> GOS – paediatric reference ranges obtained from Great Ormond Street Hospital . The panels are performed on a blood sample. By measuring the concentration of these proteins, one can obtain information about the states of various organ systems. The Service is provided free of charge by the American Society for Clinical Laboratory Science, which is one of many laboratory organizations that supports Lab Tests Online. Albumin is synthesized in the liver and makes up about 55% of all blood proteins. 2 Cu++ + Reducing Sugar Cu+ Chemistry panels are groups of tests that are routinely ordered to determine a person's general health status. 17 - HYDROXY- CORTICOSTEROIDS & 17 - KETOSTEROIDS, 24 HOUR URINE, 17 - HYDROXY- CORTICOSTEROIDS (17-OHCS), 24 HOUR URINE, 17-HYDROXYPROGESTERONE (17–OHP) STIMULATION BY ACTH, 17 - HYDROXYPROGESTERONE NEWBORN SCREEN; CAH SCREEN, 5-AMINOLEVULINIC ACID (5 -ALA), 24 HOUR URINE, 5-HIAA (5-HYDROXY INDOLE ACETIC ACID), 24 HOUR URINE, 5-AMINOLEVULINIC ACID (5 -ALA), RANDOM URINE, 5 - HIAA (5-HYDROXY INDOLE ACETIC ACID), RANDOM URINE, ANTI - ds DNA ANTIBODY CRITHIDIA, IFA IN DILUTIONS, ANTI-MOG (MYELIN OLIGODENDROCYTE GLYCOPROTEIN), SERUM, ANTI-MOG (MYELIN OLIGODENDROCYTE GLYCOPROTEIN), CSF, ACETYLCHOLINE RECEPTOR (ACHR) BLOCKING ANTIBODY, ANCA (ANTI NEUTROPHIL CYTOPLASMIC ANTIBODIES) POSITIVE REFLEX TO ANCA- MPO & ANCA-PR3, ACETYLCHOLINE RECEPTOR (ACHR) MODULATING ANTIBODY, ANTI NMDA RECEPTOR / ANTI-GLUTAMATE ANTIBODY, CSF, ANTI NMDA RECEPTOR / ANTI-GLUTAMATE ANTIBODY, SERUM, ACETYLCHOLINE RECEPTOR (ACHR) BINDING ANTIBODY, ANTI NMO (NEUROMYELITIS OPTICA) PANEL, SERUM, ANTI NMO (NEUROMYELITIS OPTICA) PANEL, CSF, ANTI NUCLEAR ANTIBODY / FACTOR (ANA / ANF), IFA (HEP-2) REFLEX TO ENA PROFILE, ACUTE LEUKEMIA DIAGNOSTIC COMPREHENSIVE PROFILE, ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) CYTOGENETICS PANEL, ACUTE MYELOID LEUKEMIA (AML) CYTOGENETICS PANEL, ANTI THYROID PEROXIDASE ANTIBODY; ANTI TPO, ADDON-SARS COV-2 (COVID-19) TOTAL ANTIBODIES, SERUM, ADENOVIRUS ANTIGEN FOR GASTROENTERITIS, STOOL, ADENOVIRUS ANTIGEN FOR RESPIRATORY INFECTIONS, ADRB2 GENOTYPING FOR BETA-2 AGONIST RESPONSIVENESS, ASCA (ANTI SACCHAROMYCES CEREVISIAE ANTIBODY) IgA, ASCA (ANTI SACCHAROMYCES CEREVISIAE ANTIBODY) PANEL IgA & IgG, ASCA (ANTI SACCHAROMYCES CEREVISIAE ANTIBODY) IgG, ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS (ABPA) PANEL, ALLERGY ASTHMA / RHINITIS SCREENING PANEL ADULT, ALCOHOL ETHYL GLUCURONIDE (EtG) & ETHYL SULPHATE (EtS) QUANTITATIVE ASSAY, URINE, ALLERGY ECZEMA SCREENING PANEL, PEDIATRIC, ALLERGY WHEEZE / RHINITIS SCREENING PANEL PEDIATRIC, ALLERGY ECZEMA PANEL FOR NON-VEGETARIANS, ALKALINE PHOSPHATASE, BONE-SPECIFIC; BSAP, ALLERGY FOOD SCREENING PANEL FOR INDIAN POPULATION, ALKALINE PHOSPHATASE BONE-SPECIFIC; BSAP, ALLERGY BERMUDA GRASS (Cynodon dactylon / Doob), ALLERGY INHALATION SCREENING PANEL FOR INDIAN POPULATION, AMINO ACID NON-KETOTIC HYPERGLYCINEMIA PANEL QUANTITATIVE, CSF & PLASMA, AMINO ACID QUANTITATIVE CSF: 45 AMINO ACIDS / FULL PANEL, AMINO ACIDS MAPLE SYRUP URINE DISEASE (MSUD) PANEL, PLASMA, AMINO ACIDS QUALITATIVE ONE DIMENSIONAL, URINE, AMINO ACIDS QUALITATIVE TWO DIMENSIONAL, URINE, AMINO ACIDS QUANTITATIVE BLOOD: 10 AMINO ACIDS, AMINO ACIDS QUANTITATIVE PLASMA: 45 AMINO ACIDS / FULL PANEL, AMINO ACIDS QUANTITATIVE URINE: 45 AMINO ACIDS / FULL PANEL, AMINO ACIDS QUANTITATIVE, URINE & PLASMA: 45 AMINO ACIDS / FULL PANEL, ALLERGY WHEEZE / RHINITIS COMPREHENSIVE PANEL ADULT, ALLERGY WHEEZE / RHINITIS COMPREHENSIVE PANEL PEDIATRIC, ALLERGY PEDIATRIC FOOD & INHALATION SCREENING PANEL FOR INDIAN POPULATION, AML ETO t(8;21) GENE REARRANGEMENT QUANTITATIVE MRD MONITOR, AML ETO t(8;21) GENE REARRANGEMENT PCR QUALITATIVE, ALLERGY COMMON PIGWEED (Kantewali Chauli), ANTI NUCLEAR ANTIBODY / FACTOR (ANA/ANF), EIA, ANTI NUCLEAR ANTIBODY / FACTOR (ANA / ANF), IFA (HEP-2) END POINT TITRE, ALLERGY SPECIFIC IgG: ALTERNARIA ALTERNATA, ANCA (ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODIES) EXTENDED PROFILE IgG, ANCA (ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES), IFA, ANCA (ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES), IFA IN DILUTIONS, ANCA-MPO (ANTI MYELOPEROXIDASE ANTIBODIES), EIA, ANCA-PR3 (SERIN PROTEINASE 3 ANTIBODIES), EIA, ALLERGY JOHNSON GRASS (Sorghum halepense / Jowar), AUTOIMMUNE BULLOUS DERMATOSES PROFILE IgG, AUTO IMMUNE ENCEPHALITIS PANEL, SERUM & CSF, AUTOIMMUNE INTERSTITIAL LUNG DISEASE (ILD) PANEL, ASPERGILLUS ANTIBODIES PANEL IgG & IgM, SERUM, ALLERGY MUG WORT (Artemisia vulgaris / Barna), ALLERGY SPECIFIC IgG: ASPERGILLUS FUMIGATUS, ALLERGY SPECIFIC IgG: CLADOSPORIUM HERBARUM, Anti-NMO (NEUROMYELITIS OPTICA ) ANTIBODY / AQUAPORIN 4, ALLERGY SPECIFIC IgG: PIGEON SERUM PROTEINS, FEATHERS & DROPPINGS, ANTI CYCLIC CITRULLINATED PEPTIDE; ANTI CCP, ALLERGY SPECIFIC IgG: PENICILLIUM CHRYSOGENUM, BOH (BAD OBSTETRIC HISTORY) ADVANCED PANEL, BOH (BAD OBSTETRIC HISTORY) EXTENDED PANEL, BETA CROSSLAPS; BETA CTx; COLLAGEN TYPE I C-TELOPEPTIDE, BIOFIRE GI (GASTROINTESTINAL) PANEL, STOOL, BIOFIRE ME (MENINGOENCEPHALITIS) ADVANTAGE, BIOFIRE ME (MENINGOENCEPHALITIS) PANEL, CSF, BIOTINIDASE ACTIVITY QUANTITATIVE, BLOOD, BRCA1 & BRCA2 MUTATION COMPREHENSIVE PANEL, BRCA1 & BRCA2 MUTATION DRUG PROFILING PANEL, BCR-ABL GENE REARRANGEMENT PCR QUALITATIVE, BCR-ABL GENE REARRANGEMENT PCR QUANTITATIVE, BENZODIAZEPINE SCREEN QUALITATIVE, URINE, BETA 2 GLYCOPROTEIN 1 PANEL IgG, IgM & IgA, BLOOD GLUCOSE R + CHOLESTEROL TOTAL+ HB% + TSH, BUCCAL SMEAR FOR BARR BODIES (SEX CHROMATIN), BLOOD PICTURE; PERIPHERAL BLOOD SMEAR EXAMINATION, C1 ESTERASE INHIBITOR FUNCTIONAL; C1 INACTIVATOR FUNCTIONAL, CULTURED AFB ANTITUBERCULAR DST, RAPID 10 DRUGS PANEL, C1 ESTERASE INHIBITOR PROTEIN QUANTITATION; C1 INHIBITOR QUANTITATIVE, CULTURED AFB ANTITUBERCULAR DST, RAPID 11 DRUGS PANEL, CHROMOSOME ANALYSIS (KARYOTYPE) COUPLE, BLOOD, CULTURED AFB ANTITUBERCULAR DST, RAPID 12 DRUGS PANEL, CULTURED AFB ANTITUBERCULAR DST, RAPID 15 DRUGS PANEL, CULTURED AFB ANTITUBERCULAR DST, RAPID 4 DRUGS PANEL, CHROMOSOME INTERPHASE PROFILING, AMNIOTIC FLUID, CULTURED AFB ANTITUBERCULAR DST, RAPID 5 DRUGS PANEL, CHROMOSOME INTERPHASE PROFILING, PRODUCTS OF CONCEPTION, CULTURED AFB ANTITUBERCULAR DST, AMIKACIN, CHROMOFIC CHROMOSOME SNP MICROARRAY 750K, HIGH RESOLUTION, CULTURED AFB ANTITUBERCULAR DST, CAPREOMYCIN, CHROMOTOUCH CHROMOSOME SNP MICROARRAY OPTIMA, PRENATAL, CULTURED AFB ANTITUBERCULAR DST, CLOFAZIMINE, CHROMOTOUCH CHROMOSOME SNP MICROARRAY OPTIMA, PRODUCTS OF CONCEPTION, CULTURED AFB ANTITUBERCULAR DST, CYCLOSERINE, CHROMOSOME XON MICROARRAY, HIGH RESOLUTION, CULTURED AFB ANTITUBERCULAR DST, ETHAMBUTOL, CHROMULTRA CHROMOSOME SNP HD MICROARRAY, CULTURED AFB ANTITUBERCULAR DST, ETHIONAMIDE, CULTURED AFB ANTITUBERCULAR DST, ISONIAZID, CHRONIC LYMPHOCYTIC LEUKEMIA (CLL),  PROGNOSTIC PANEL, CULTURED AFB ANTITUBERCULAR DST, KANAMYCIN, CHRONIC LYMPHOCYTIC LEUKEMIA (CLL), MUTATIONS DETECTION COMPREHENSIVE PANEL, CULTURED AFB ANTITUBERCULAR DST, LEVOFLOXACIN, CHRONIC LYMPHOCYTIC LEUKEMIA (CLL), MUTATIONS DETECTION PANEL 1, CULTURED AFB ANTITUBERCULAR DST, MOXIFLOXACIN, CHRONIC LYMPHOCYTIC LEUKEMIA (CLL), MUTATIONS DETECTION PANEL 2, CA 27.29 & CA 15.3; BREAST CANCER MARKERS PANEL, CULTURED AFB ANTITUBERCULAR DST, OFLOXACIN, CIRCULATING TUMOR CELLS (CTC) FOR BREAST CANCER, CULTURED AFB ANTITUBERCULAR DST, PYRAZINAMIDE, CIRCULATING TUMOR CELLS (CTC) FOR COLORECTAL CANCER, CULTURED AFB ANTITUBERCULAR DST, RIFAMPICIN, CIRCULATING TUMOR CELLS (CTC) FOR PROSTATE CANCER, CULTURED AFB ANTITUBERCULAR DST, STREPTOMYCIN, CALCITONIN STIMULATION BY CALCIUM - PENTAGASTRIN, CULTURED ANAEROBIC BACTERIA IDENTIFICATION, CULTURED MOLD ANTIFUNGAL DRUG SENSITIVITY (DST) TEST, CULTURE ESBL (EXTENDED SPECTRUM BETA-LACTAMASE) SCREENING, CULTURE, FUNGUS, BLOOD / BODY FLUIDS RAPID, CYTOMEGALOVIRUS (CMV) ANTIBODIES PANEL, IgG & IgM, CYTOMEGALOVIRUS (CMV) DNA, QUANTITATIVE PCR, CULTURE MRSA (METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS) SCREENING, CULTURE, MYCOBACTERIUM ATYPICAL(NON TUBERCULOUS MYCOBACTERIUM-NTM), CANCER TARGETED GENE PANEL: COLON / COLORECTAL, CANCER TARGETED GENE PANEL: GASTROINTESTINAL STROMAL TUMOR (GIST), CULTURE WATER: PRESUMPTIVE COLIFORM COUNT, CANNABINOIDS (Delta-9-THC Metabolites) / MARIJUANA SCREEN, URINE, COLLAGEN CROSS-LINKED N-TELOPEPTIDE (NTx), RANDOM URINE, CYSTICERCOSIS (TAENIA SOLIUM) ANTIBODY, IgG, CARDIOLIPIN ANTIBODIES PANEL IgG, IgA & IgM, CYTOLOGY (PAP SMEAR) GENITAL FEMALE, CONVENTIONAL, CYTOLOGY (PAP SMEAR) GENITAL FEMALE, LIQUID BASED, CATECHOLAMINES FRACTIONATED, 24-HOUR URINE, CYTOMEGALOVIRUS, INTERFERON GAMMA RELEASE ASSAY (IGRA), CATECHOLAMINES FRACTIONATED, RANDOM URINE, CHIMERISM PRE-ENGRAFTMENT DONOR & RECIPIENT, COMPLETE BLOOD COUNT ADVANCED; CBC ADVANCED, CHIMERISM SPLIT CELL ANALYSIS - MYELOID CELL (CD15), CHIMERISM SPLIT CELL ANALYSIS - T Cell (CD3), CHIMERISM SPLIT CELL ANALYSIS - B CELL (CD19), CULTURE AEROBIC BRONCHOALVEOLAR LAVAGE (BAL), CONGENITAL HYPOTHYROIDISM CONFIRMATORY PANEL, SERUM, CULTURE AEROBIC ENDOTRACHEAL (ET) SECRETIONS, CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE PCR QUALITATIVE, CULTURE AEROBIC MISCELLANEOUS WITH GRAM STAIN, CORTISOL SERUM: MORNING & EVENING SAMPLES, CULTURE AFB (MYCOBACTERIUM) RAPID WITH PNB TEST, CORTISOL SUPPRESSION BY DEXAMETHASONE, OVERNIGHT HIGH DOSE, CORTISOL SUPPRESSION BY DEXAMETHASONE, OVERNIGHT LOW DOSE, CULTURE, BRUCELLA*DOES NOT INCLUDE ANTIBIOTIC SENSITIVITY*, CULTURED AEROBIC BACTERIA IDENTIFICATION, CULTURED AEROBIC BACTERIA IDENTIFICATION AND SENSITIVITY, CULTURED AFB ANTITUBERCULAR DST, RAPID 16 DRUGS PANEL, CULTURED AFB ANTITUBERCULAR DST, LINEZOLID, CULTURED AFB DRUG RESISTANT (DR MYCOBACTERIUM) ANTI-TUBERCULAR DST, RAPID 15 DRUGS PANEL, CULTURED AFB OTHER THAN TUBERCULOSIS (MOTT), DST FOR RAPID GROWERS, CULTURED AFB OTHER THAN TUBERCULOSIS (MOTT), DST FOR SLOW GROWERS, CRYPTOSPORIDIUM / ISOSPORA IDENTIFICATION, STOOL, CULTURED AFB ANTITUBERCULAR DST, RAPID 19 DRUGS PANEL, CULTURED AFB ANTITUBERCULAR DST, CLARITHROMYCIN, CSF LEAKAGE EVALUATION (NASAL/EAR DISCHARGE), CULTURED AFB ANTITUBERCULAR DST, RIFABUTIN, CHROMOSOME ANALYSIS FOR HEMATOLOGIC MALIGNANCY, CULTURED AFB ANTITUBERCULAR DST, RAPID 10 SECOND LINE DRUGS PANEL, CHROMOSOME ANALYSIS, PRODUCTS OF CONCEPTION REFLEX TESTING TO FISH FOR ANEUPLOIDY DETECTION, CULTURED AFB ANTITUBERCULAR DST, RAPID 5 SECOND LINE DRUGS PANEL, CHROMOSOME ANALYSIS HIGH RESOLUTION, NEONATAL, DPYD (DEOXYPYRIDINOLINE) CROSSLINKS, URINE, DES-GAMMA CARBOXY PROTHROMBIN (DCP)/PIVKA II, SERUM, Dialysis SARS-COV-2 (COVID-19) SCREENING PROFILE, DRPLA (DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY) GENE ANALYSIS, DISSEMINATED INTRAVASCULAR COAGULATION (DIC) PROFILE, DUCHENNE / BECKER MUSCULAR DYSTROPHY (DMD / BMD) GENE MUTATION, DEEP VEIN THROMBOSIS PANEL; DVT PANEL, DHEA SULPHATE; DEHYDROEPIANDROSTERONE SULPHATE, DENGUE & CHIKUNGUNYA VIRUSES, PCR QUALITATIVE, DIPHTHERIA-PERTUSSIS-TETANUS ANTIBODY PANEL IgG, DLC (DIFFERENTIAL LEUCOCYTE COUNT), AUTOMATED, DLC (DIFFERENTIAL LEUCOCYTE COUNT), FLUID, EPSTEIN BARR VIRUS (EBV), QUALITATIVE PCR, ECHINOCOCCUS DETECTION FOR SCOLICES IN HYDATID CYST FLUID, ENTEROHEMORRHAGIC E.COLI VEROTOXIN 1 & 2 ANTIGEN, ECHINOCOCCUS (HYDATID SEROLOGY) IgG, SERUM, EPIDERMAL (PEMPHIGUS) ANTIBODY, IFA IN DILUTIONS, EPISODIC ATAXIA COMPREHENSIVE PROFILE, HOTSPOT, EPSTEIN BARR VIRUS ANTIBODIES TO VIRAL CAPSID ANTIGEN (VCA), IgG & IgM, EXTRACTABLE NUCLEAR ANTIGENS (ENA)/ANTI NUCLEAR ANTIBODIES (ANA), QUALITATIVE PROFILE, EXTRACTABLE NUCLEAR ANTIGENS (ENA)/ANTI NUCLEAR ANTIBODIES (ANA), QUANTITATIVE PROFILE, EPSTEIN-BARR VIRUS ANTIBODY TO EARLY ANTIGEN (D), IgG, EPSTEIN-BARR VIRUS EARLY RNA (EBER-ISH) IN-SITU-HYBRIDIZATION, EPSTEIN-BARR VIRUS ANTIBODY TO NUCLEAR ANTIGEN (EBNA), IgG, ENDOMYSIAL ANTIBODY IgA, IFA IN DILUTIONS, EPSTEIN-BARR VIRUS ANTIBODY TO VIRAL CAPSID ANTIGEN (VCA), IgG, EPSTEIN BARR VIRUS (EBV), QUANTITATIVE PCR, EPSTEIN-BARR VIRUS ANTIBODY TO VIRAL CAPSID ANTIGEN (VCA), IgM, FISH - FOLLICULAR LYMPHOMA (IGH/BCL2) t(14;18), FISH - PRENATAL COMPREHENSIVE SCREENING PANEL 1, FISH - MDS Panel - CHROMOSOMES 5q, 7q, 8q & 20q, FISH - MICRODELETION DETECTION FOR WILLIAMS SYNDROME, FISH - MULTIPLE MYELOMA WITH POSITIVE SELECTION OF CD138 CELLS, FISH - Multiple Myeloma with CD138 positive selection cells ( 5 Probes), FISH - t(8;14) OR MYC/IGH FOR BURKITT & NON-HODGKIN LYMPHOMA, FIBRINOGEN DEGRADATION PRODUCTS (FDP), BLOOD, FACTOR XIII (CLOT SOLUBILITY) FUNCTIONAL, QUALITATIVE, FISH - NSCLC (NON-SMALL CELL LUNG CANCER) ALK1 & ROS1, FSH & LH STIMULATION BY GONADOTROPIN RELEASING HORMONE (GnRH), FIP1L1-PGDFRA GENE REARRANGEMENT DETECTION, FUNGUS EXAMINATION, ROUTINE: KOH CALCOFLUOR WHITE PREPARATION, FISH - 14q32.3 OR LSI IGH GENE BREAKAPART, FISH - PDGFR ALPHA (4q12) GENE REARRANGEMENT, FISH - PDGFR BETA (5q33) GENE REARRANGEMENT, FLUID EXAMINATION, ROUTINE, BODY FLUIDS, FLUID EXAMINATION, ROUTINE, CSF/ NASAL FLUID, FISH - 22q DELETION OR LSI Di GEORGE / VCFS, FISH - PRENATAL SCREENING PANEL CHROMOSOMES 13,18, 21, X & Y, FISH - RARA (17q21) VARIANT TRANSLOCATION, FISH - AMNIO ONE PROBE: TRISOMY 21 / DOWN SYNDROME, FISH - AMNIO THREE PROBES: TRISOMY 18, X & Y, FISH - AMNIO TWO PROBES: TRISOMY 13 & 21, FISH - ANEUPLOIDY DETECTION, PRODUCTS OF CONCEPTION (POC) USING CHROMOSOMES 13, 18, 21, X & Y, FISH - SYNOVIAL SARCOMA (SS18 / SYT ) 18q11.2 GENE REARRANGEMENT, FRAGILE X TREMOR / ATAXIA SYNDROME (FXTAS), FISH - BCR / ABL OR PHILADELPHIA TRANSLOCATION, FISH - EWING SARCOMA (EWS), 22q12 (EWSR1) REARRANGEMENT, FEBRILE AGGLUTININS PANEL Combined Brucella, Widal and Weil Felix tests panel, GLUCOSE TOLERANCE TEST (GTT) PREGNANCY, 100g GLUCOSE, GLUCOSE TOLERANCE TEST (GTT), PREGNANCY, 75g GLUCOSE, GLOMERULAR BASEMENT MEMBRANE (GBM) ANTIBODY, IgG, GM2 GANGLIOSIDOSIS QUANTITATIVE, BLOOD; TAY SACHS & SANDHOFF DISEASE, GFR (GLOMERULAR FILTRATION RATE), ESTIMATED, GRAM STAIN FOR BACTERIAL VAGINOSIS (BV), VAGINAL SWAB, GLUCOSE CHALLENGE TEST (GCT); GLUCOSE 1 HOUR OBSTETRICAL, GAD-65 (GLUTAMIC ACID DECARBOXYLASE- 65), IgG, GLUCOSE CHALLENGE TEST (GCT), PREGNANCY, 75g GLUCOSE, GALACTOMANNAN (ASPERGILLUS ANTIGEN), BRONCHOALVEOLAR LAVAGE, GALACTOMANNAN (ASPERGILLUS ANTIGEN), SERUM, GALACTOSE -1-PHOSPHATE QUANTITATIVE, BLOOD, GALACTOSEMIA CLASSICAL (TRANSFERASE) QUANTITATIVE, BLOOD, GALACTOSEMIA (EPIMERASE) QUANTITATIVE, BLOOD, GLUCOSE FASTING (F) AND POST MEAL (PP), 2 HOURS, GALACTOSEMIA (GALT) GENE MUTATION DETECTION, GENETIC MAPPING FOR CARDIOVASCULAR DISORDERS, GENETIC MAPPING FOR GYNECOLOGICAL DISORDERS, GLUCOSE POST PRANDIAL (PP) 2 HOURS POST MEAL, GENEXPERT ULTRA (NEXT GENERATION) MTB WITH RIFAMPICIN RESISTANCE, SEMI QUANTITATIVE PCR, GLIADIN DEAMIDATED ANTIBODIES PANEL, IgA & IgG, HCG BETA TOTAL QUANTITATIVE, TUMOR MARKER, HEPATITIS G VIRUS (HGV) RNA DETECTION PCR, HISTOPATHOLOGY SPECIAL STAIN: PERIODIC ACID SCHIFF (PAS), H1N1 (SWINE FLU) QUALITATIVE REAL TIME PCR, HISTOPATHOLOGY SPECIAL STAIN: AMYLOID (CONGO RED), HAINS MYCOBACTERIUM TUBERCULOSIS FIRST LINE DRUG RESISTANCE PROFILE, HISTOPATHOLOGY SPECIAL STAIN: PHOSPHOTUNGSTIC ACID HEMATOXYLIN (PTAH), HAINS MYCOBACTERIUM TUBERCULOSIS FIRST & SECOND LINE DRUG RESISTANCE PROFILE, HAINS MYCOBACTERIUM TUBERCULOSIS SECOND LINE DRUG RESISTANCE PROFILE, HISTOPATHOLOGY SPECIAL STAIN: VAN GIESONS, HAM TEST; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) SCREENING TEST, HERPES SIMPLEX VIRUS (HSV) 1 ANTIBODIES PANEL IgG & IgM, SERUM, HERPES SIMPLEX VIRUS (HSV) 1+2 IgM, SERUM, HERPES SIMPLEX VIRUS (HSV) TYPE 1 & 2, PCR QUALITATIVE, HIV 1 RNA QUANTITATIVE REAL TIME PCR WITH CD3, CD4 / CD8 (IMMUNE DEFICIENCY PANEL 2) MARKERS, HERPES SIMPLEX VIRUS (HSV) TYPE 2 PCR QUALITATIVE, HIV 1 RNA QUANTITATIVE REAL TIME PCR WITH CD3 / CD4 (IMMUNE DEFICIENCY PANEL 4) MARKERS, HBDH; ALPHA-HYDROXYBUTYRATE DEHYDROGENASE, HERPES SIMPLEX VIRUS (HSV) TYPE I PCR QUALITATIVE, HEPATITIS B SURFACE ANTIGEN; HBsAg; AUSTRALIA ANTIGEN, HERPES VIRUS 6 (HHV-6) ANTIBODIES PANEL IgG & IgM, HLA SINGLE ANTIGEN BEAD ASSAY FOR CLASS I & II IgG ANTIBODIES; DSA-SAB CLASS I & II, HEPATITIS B SURFACE ANTIGEN (HBsAg), QUANTITATIVE, HERPES SIMPLEX VIRUS (HSV) 1+2 ANTIBODIES PANEL IgG & IgM, SERUM, HEPATITIS B VIRAL DNA (HBV DNA) QUANTITATIVE REAL TIME PCR, HERPES SIMPLEX VIRUS (HSV) 2 ANTIBODIES PANEL IgG & IgM, SERUM, HCG BETA TOTAL QUANTITATIVE, 24 HOUR URINE, HCG BETA TOTAL QUANTITATIVE, RANDOM URINE, HUMAN HERPESVIRUS 6 (HHV6) QUALITATIVE PCR, HEPATITIS C VIRAL RNA (HCV RNA) QUANTITATIVE REAL TIME PCR, HUMAN HERPES VIRUS 7 (HHV7) QUALITATIVE PCR, HELICOBACTER PYLORI ANTIBODIES PANEL, IgA & IgG, HELICOBACTER PYLORI ANTIGEN, RAPID STOOL TEST, HLA - CELIAC DISEASE (DR-DQB1-DQA1 HAPLOTYPE ASSOCIATION INCLUDING DQ2,DQ8), HLA DNA HIGH RESOLUTION TYPING- A, B, C, DR & DQ, HYPOTHYROIDISM / HASHIMOTO'S DISEASE PANEL, HLA MIXED ANTIBODY SCREEN - PRA CLASS I, II & MICA, HLA DNA HIGH RESOLUTION TYPING - DQB1 LOCUS, HLA DNA HIGH RESOLUTION TYPING - DRB1 LOCUS, HLA DNA TYPING FOR BONE MARROW TRANSPLANT: 10 ANTIGENS PCR, HLA DNA TYPING FOR BONE MARROW TRANSPLANT: 6 ANTIGENS LUMINEX, HLA DNA TYPING FOR KIDNEY / LIVER TRANSPLANT PCR, HLA DNA TYPING HIGH RESOLUTION BY NEXT GENERATION SEQUENCING (NGS), HEPARIN INDUCED THROMBOCYTOPENIA (HIT) / ANTI PLATELET FACTOR 4-HEPARIN (PF4-H), IgG QUANTITATIVE, HOMA-IR; INSULIN RESISTANCE INDEX C-PEPTIDE MODEL, HLA DONOR SPECIFIC IgG ANTIBODIES & PANEL REACTIVE ANTIBODIES SCREEN PROFILE, HPV, CHLAMYDIA TRACHOMATIS & NEISSERIA GONORRHEA PCR PANEL QUALITATIVE, HPV (HUMAN PAPILLOMA VIRUS) DETECTION & GENOTYPING QUALITATIVE PCR, HHH SYNDROME; HYPERORNITHINEMIA - HYPERAMMONEMIA - HOMOCITRULLINURIA SYNDROME, HISTO / CYTOPATHOLOGY / IMMUNOHISTOCHEMISTRY (IHC) PHOTOMICROGRAPH, HISTO/CYTOPATHOLOGY SLIDE(S) / BLOCK(S) ISSUE, HEPATITIS B CORE ANTIBODY (Anti-HBc), IgM, HISTO/CYTOPATHOLOGY, SLIDES (S) / BLOCKS (S) ISSUE, HEPATITIS B CORE ANTIBODY (Anti-HBc), TOTAL, HLA DSA (DONOR SPECIFIC IgG ANTIBODIES), CLASS I & II, HISTOPATHOLOGY BIOPSY: LARGE COMPLEX / CANCER SPECIMEN, HLA DSA-SAB CLASS I IgG ANTIBODIES WITH C1q SCREEN, HLA DSA-SAB CLASS II IgG ANTIBODIES WITH C1q SCREEN, HLA HYPERSENSITIVITY TO ABACAVIR (B*57:01), HLA HYPERSENSITIVITY TO ALLOPURINOL (B*58:01), HISTOPATHOLOGY DIRECT IMMUNOFLUORESCENCE (DIF) SKIN / CONJUNCTIVAL BIOPSY PANEL, HLA HYPERSENSITIVITY TO CARBAMAZEPINE & PHENYTOIN (B*15:02), HISTOPATHOLOGY DIRECT IMMUNOFLUORESCENCE (DIF) KIDNEY BIOPSY, HLA - NARCOLEPSY (DRB1*15, DQB1*06:02, DQA1*01:02), Hepatitis B Surface Antigen (Hbsag) Rapid Screening, HISTOPATHOLOGY DIRECT IMMUNO-FLUORESCENCE (DIF) SKIN / CONJUNCTIVAL BIOPSY, COMPLEMENT C3, HLA - PANEL REACTIVE IgG ANTIBODIES (PRA), CLASS II QUANTITATIVE, HEPATITIS B SURFACE ANTIGEN (HBsAg) CONFIRMATION, HISTOPATHOLOGY DIRECT IMMUNOFLUORESCENCE (DIF) SKIN / CONJUNCTIVAL BIOPSY, IgA, HLA - PANEL REACTIVE IgG ANTIBODIES (PRA) CLASS I, QUANTITATIVE, HEPATITIS B VIRAL DRUG RESISTANCE & GENOTYPING, HISTOPATHOLOGY DIRECT IMMUNO-FLUORESCENCE (DIF) SKIN / CONJUNCTIVAL BIOPSY, IgG, HLA - PANEL REACTIVE IgG ANTIBODIES (PRA) SCREEN, HEPATITIS B VIRAL (HBV DNA) QUANTITATIVE ULTRA, HISTOPATHOLOGY DIRECT IMMUNO-FLUORESCENCE (DIF) SKIN / CONJUNCTIVAL BIOPSY, IgM, HLA PRE-TRANSPLANT WORKUP NON SENSITIZED RECIPEINT PANEL1, HEPATITIS B VIRUS GENOTYPING, DRUG RESISTANCE & QUANTITATIVE PCR, HISTOPATHOLOGY DIRECT IMMUNO-FLUORESCENCE (DIF) SKIN / CONJUNCTIVAL BIOPSY, COMPLEMENT C1q, HLA PRE-TRANSPLANT WORKUP NON SENSITIZED RECIPIENT PANEL1, HEPATITIS B VIRUS PCR QUALITATIVE; HBV DNA PCR QUALITATIVE, HLA PRE-TRANSPLANT WORKUP SENSITIZED RECIPIENT PANEL 3, HLA PRE-TRANSPLANT WORKUP SENSITIZED RECIPIENT PANEL 4, HEPATITIS C VIRAL RNA PCR QUALITATIVE; HCV RNA PCR QUALITATIVE, HISTOPATHOLOGY SPECIAL STAIN: ACID FAST (Z N STAIN), HISTOPATHOLOGY SPECIAL STAIN: ALCIAN BLUE, HLA PRE-TRANSPLANT WORKUP SENSITIZED RECIPIENT PANEL 5, HEPATITIS C VIRAL RNA (HCV RNA) QUANTITATIVE ULTRA, HISTOPATHOLOGY SPECIAL STAIN: COPPER (RHODANINE), Hepatitis C Virus (HCV) Rapid Screening Test, HISTOPATHOLOGY SPECIAL STAIN: FONTANA MASSON, HLA SINGLE ANTIGEN BEAD ASSAY FOR CLASS I IgG ANTIBODIES; DSA-SAB CLASS I, HISTOPATHOLOGY SPECIAL STAIN: GOMORI’S METHENAMINE SILVER, HLA SINGLE ANTIGEN BEAD ASSAY FOR CLASS II IgG ANTIBODIES; DSA-SAB CLASS II, HISTOPATHOLOGY SPECIAL STAIN: IRON (PERL’S STAIN), HISTOPATHOLOGY SPECIAL STAIN: MASSON TRICHROME, HEPATITIS C VIRAL RNA GENOTYPE 1 NS5a DRUG RESISTANCE, HISTOPATHOLOGY SPECIAL STAIN: MUCICARMINE, INTERLEUKIN-2 RECEPTOR ALPHA CHAIN; IL-2R, IMMUNOHISTOCHEMISTRY, ACTIN (SMOOTH MUSCLE ACTIN), IMMUNOHISTOCHEMISTRY, SINGLE MARKER WITH INTERPRETATION, INTERLEUKIN 28B rs12979860 & rs 8099917 GENOTYPING QUALITATIVE PCR, IMMUNOHISTOCHEMISTRY, AFP (ALPHA FETO PROTEIN), IMMUNOHISTOCHEMISTRY, HUMAN CHORIONIC GONADOTROPIN (HCG), INTERLEUKIN-6 (IL-6) SARS-COV-2 (COVID-19) ADVANCED PANEL, INTERLEUKIN-6 (IL-6) SARS-COV-2 (COVID-19) BASIC PANEL, Inv16 (p13q22) / t(16;16)(p13;q22) GENE REARRANGEMENT QUALITATIVE PCR, IMMUNOHISTOCHEMISTRY, LAMBDA LIGHT CHAINS, IMMUNOHISTOCHEMISTRY MYELOPEROXIDASE (MPO), IMMUNOPHENOTYPING BY FLOW CYTOMETRY: LEUKEMIA DIAGNOSTIC COMPREHENSIVE PROFILE ANY 6 MARKERS, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: LEUKEMIA DIAGNOSTIC PANEL ACUTE LEUKEMIA - T, B or MYELOID, IMMUNOHISTOCHEMISTRY, NEUROFILAMENT POLYPEPTIDE, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: LEUKEMIA DIAGNOSTIC PANEL-AML CHARACTERIZATION, IMMUNOHISTOCHEMISTRY, NEURON SPECIFIC ENOLASE (NSE), IMMUNOPHENOTYPING BY FLOW CYTOMETRY: LEUKEMIA DIAGNOSTIC PANEL- CLL/HCL/SLL BASIC, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: LEUKEMIA DIAGNOSTIC PANEL CUSTOMIZED ANY 10 MARKERS, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: LEUKEMIA DIAGNOSTIC PANEL-PLASMA CELL DYSCRASIAS, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: LEUKEMIA / LYMPHOMA DIAGNOSTIC PANEL-CHRONIC LYMPHOPROLIFERATIVE DISORDERS, T & B CELL, IMMUNOPHENOTYPING BY FLOW CYTOMETRY: LEUKEMIA MONITORING PANEL-HAIRY CELL, IMMUNOHISTOCHEMISTRY, POLYOMA BK VIRUS (SV 40), IMMUNOPHENOTYPING BY FLOW CYTOMETRY: LYMPHOMA DIAGNOSTIC PANEL, IMMUNOHISTOCHEMISTRY, PROGESTERONE RECEPTOR (PR), IMMUNOPHENOTYPING BY FLOW CYTOMETRY: OBSTETRIC FLOW PANEL, IBD (INFLAMMATORY BOWEL DISEASE) SCREENING PANEL, IMMUNOHISTOCHEMISTRY, PROSTATE SPECIFIC ANTIGEN (PSA), IMMUNOHISTOCHEMISTRY, ISOCITRATE DEHYDROGENASE (IDH-1), IMMUNOHISTOCHEMISTRY, SERUM ASSOCIATED AMYLOID (SAA), IMMUNOHISTOCHEMISTRY, TTF-1 (THYROID TRANSCRIPTION FACTOR-1), INFLUENZA LIKE ILLNESS / ILI SARS-CoV-2 (COVID-19) PANEL, IMMUNOHISTOCHEMISTRY, CEA (CARCINOEMBRYONIC ANTIGEN), IMMUNOHISTOCHEMISTRY, LUTEINIZING HORMONE (LH), IMATINIB RESISTANCE MUTATION ANALYSIS; IRMA, IMMUNOHISTOCHEMISTRY, HER-2 / ERBB2 (BREAST), IMMUNOHISTOCHEMISTRY, CHROMOGRANIN-A (CGA), IMMUNOHISTOCHEMISTRY, CYTOMEGALOVIRUS (CMV), IMMUNOHISTOCHEMISTRY, LUNG NON-SMALL CELL CARCINOMA (NSCC) PANEL, IMMIGRATION / IMMUNIZATION CHECK PANEL, ADVANCED, IMMUNOHISTOCHEMISTRY, CYTOKERATIN- 19 (CK-19), IMUNOHISTOCHEMISTRY, MICROSATELLITE INSTABILITY PANEL, IMMIGRATION / IMMUNIZATION CHECK PANEL BASIC, IMMUNOHISTOCHEMISTRY, CYTOKERATIN-20 (CK-20), IMMUNOHISTOCHEMISTRY, CYTOKERATIN- 7 (CK-7), IMMUNOHISTOCHEMISTRY, CYTOKERATIN (PANCYTOKERATIN), IMMUNOHISTOCHEMISTRY, EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR), IMMUNOHISTOCHEMISTRY, EPITHELIAL MEMBRANE ANTIGEN (EMA), IMMUNOHISTOCHEMISTRY, FOLLICLE STIMULATING HORMONE (FSH), IMMUNOHISTOCHEMISTRY, NEUROENDOCRINE TUMOR PANEL, IMMUNOFIXATION ELECTROPHORESIS (IFE), 24 HOUR URINE, IMMUNOHISTOCHEMISTRY, GLIAL FIBRILLARY ACIDIC PROTEIN (GFAP), IMMUNOHISTOCHEMISTRY, GROWTH HORMONE (GH), IMMUNOHISTOCHEMISTRY, HEPATOCYTE SPECIFIC ANTIGEN (HSA), Inv16 (p13q22) / t(16;16)(p13;q22) GENE REARRANGEMENT QUANTITATIVE MRD MONITOR, IMMUNOPHENOTYPING BY FLOW CYTOMETRY, CD16 + 56, IMMUNOPHENOTYPING BY FLOW CYTOMETRY, CD34 (STEM CELL) ENUMERATION, IMMUNOHISTOCHEMISTRY, PD-L1 SP263 (VENTANA), IMMUNOHISTOCHEMISTRY, PDL1 SP142 (Ventana), IMMUNOGLOBULIN IgG SYNTHESIS INDEX & RATE, IMMUNOPHENOTYPING BY FLOW CYTOMETRY, CD103, IMMUNOPHENOTYPING BY FLOW CYTOMETRY, CD10 (CALLA), IMMUNOPHENOTYPING BY FLOW CYTOMETRY, CD117, IMMUNOPHENOTYPING BY FLOW CYTOMETRY, CD11c, IMMUNOPHENOTYPING BY FLOW CYTOMETRY, CD123, IMMUNOPHENOTYPING BY FLOW CYTOMETRY, CD13, IMMUNOPHENOTYPING BY FLOW CYTOMETRY, CD138, IMMUNOHISTOCHEMISTRY, BLADDER VS PROSTATE CARCINOMA PANEL, IMMUNOPHENOTYPING BY FLOW CYTOMETRY, CD14, IMMUNOHISTOCHEMISTRY, GERM CELL TUMOUR PANEL, IMMUNOPHENOTYPING BY FLOW CYTOMETRY, CD15, IMMUNOPHENOTYPING BY FLOW CYTOMETRY, CD19, IMMUNOHISTOCHEMISTRY, PITUITARY ADENOMA PANEL, IMMUNOPHENOTYPING BY FLOW CYTOMETRY, CD1a, IMMUNOHISTOCHEMISTRY, PROSTATE BENIGN VS MALIGNANT PANEL, IMMUNOPHENOTYPING BY FLOW CYTOMETRY, CD20, IMMUNOPHENOTYPING BY FLOW CYTOMETRY, CD22, IMMUNOHISTOCHEMISTRY, THYROID CARCINOMA PANEL, IMMUNOPHENOTYPING BY FLOW CYTOMETRY, CD23, IMMUNOHISTOCHEMISTRY, THYROID STIMULATING HORMONE (TSH), IMMUNOPHENOTYPING BY FLOW CYTOMETRY, CD25, IMMUNOHISTOCHEMISTRY, SINGLE MARKER WITHOUT IINTERPRETATION, IMMUNOPHENOTYPING BY FLOW CYTOMETRY, CD33, IMMUNOHISTOCHEMISTRY, ANY 5 MARKERS WITHOUT INTERPRETATION, IMMUNOHISTOCHEMISTRY CARBONIC ANHYDRASE-9 (CA-9), IMMUNOPHENOTYPING BY FLOW CYTOMETRY, CD34, IMMUNOHISTOCHEMISTRY, ANY 3 MARKERS WITHOUT INTERPRETATION, IMMUNOPHENOTYPING BY FLOW CYTOMETRY, CD36, IMMUNOPHENOTYPING BY FLOW CYTOMETRY, CD38, IMMUNOPHENOTYPING BY FLOW CYTOMETRY, CD41a, IMMUNOPHENOTYPING BY FLOW CYTOMETRY, CD45, IMMUNOPHENOTYPING BY FLOW CYTOMETRY, CD61, IMMUNOPHENOTYPING BY FLOW CYTOMETRY, CD64, IMMUNOPHENOTYPING BY FLOW CYTOMETRY, CD79a, IMMUNOHISTOCHEMISTRY, DIGITAL BREAST CANCER PANEL-1, IMMUNOPHENOTYPING BY FLOW CYTOMETRY, CD79b, IMMUNOHISTOCHEMISTRY, DIGITAL BREAST CANCER PANEL-3, IMMUNOPHENOTYPING BY FLOW CYTOMETRY, CD MPO, IMMUNOHISTOCHEMISTRY, DIGITAL BREAST CANCER PANEL-4, IMMUNOPHENOTYPING BY FLOW CYTOMETRY, FMC-7, IMMUNOPHENOTYPING BY FLOW CYTOMETRY, GLYCOPHORIN, IMMUNOPHENOTYPING BY FLOW CYTOMETRY, HLA DR, IMMUNOPHENOTYPING BY FLOW CYTOMETRY, IgG HEAVY CHAIN CYTOPLASMIC, IMMUNOHISTOCHEMISTRY, GLUTAMINE SYNTHETASE, IMMUNOPHENOTYPING BY FLOW CYTOMETRY, IgG HEAVY CHAIN SURFACE, IMMUNOHISTOCHEMISTRY GLYCOPHORIN A (GPA), IMMUNOPHENOTYPING BY FLOW CYTOMETRY, IgM HEAVY CHAIN CYTOPLASMIC, IMMUNOPHENOTYPING BY FLOW CYTOMETRY, IgM HEAVY CHAIN SURFACE, IMMUNOPHENOTYPING BY FLOW CYTOMETRY, KAPPA & LAMBDA LIGHT CHAINS, IMMUNOPHENOTYPING BY FLOW CYTOMETRY, ZAP-70, INSULIN FASTING (F) & POST PRANDIAL (PP) PANEL, IMMUNOHISTOCHEMISTRY, ESTROGEN RECEPTOR (ER), IMMUNOPHENOTYPING BY FLOW CYTOMETRY, CD49d, IMMUNOHISTOCHEMISTRY, 34-BETA E12 / HMW-CK, JAK 2 V617F REFLEX TO JAK 2 EXON 12 MUTATION DETECTION, JAPANESE ENCEPHALITIS VIRUS (JEV) DETECTION PCR, JAK 2 V617F, CALR & MPL MUTATION DETECTION PROFILE, KETONE BODY (BETA HYDROXYBUTYRATE), SERUM, KIDNEY STONE FORMATION THERAPEUTIC MONITORING PANEL, LEISHMANIA (KALA AZAR) rK-39 ANTIBODY, SERUM, LIVER KIDNEY MICROSOMAL (LKM) ANTIBODY IN DILUTIONS IFA, LEUKEMIA GENETIC PROFILE - ANY 6 MARKERS PCR QUALITATIVE, Lp-PLA2 (LIPOPROTEIN ASSOCIATED PHOSPHOLIPASE A2) ACTIVITY, LEBER'S HEREDITARY OPTIC NEUROPATHY (LHON) MITOCHONDRIAL MUTATION DETECTION, LYME DISEASE (BORRELIA BURGDORFERI) ANTIBODIES IgG & IgM, LEGIONELLA PNEUMOPHILA IgG ANTIBODY, SERUM, LYME DISEASE (BORRELIA BURGDORFERI) DNA QUALITATIVE REAL TIME PCR, LEIGH SYNDROME MITOCHONDRIAL MUTATION DETECTION, LYME DISEASE (BORRELIA BURGDORFERI) IgG & IgM IMMUNOBLOT, LYME DISEASE (BORRELIA BURGDORFERI) IgG IMMUNOBLOT, LIPOPROTEIN FRACTIONATION, ULTRACENTRIFUGATION, LEUCOCYTE ADHESION DEFICIENCY (LAD I & II), LEUCOCYTE ALKALINE PHOSPHATASE SCORE; LAP SCORE, LIVER KIDNEY MICROSOMAL (LKM) ANTIBODY IFA, MUCOPOLYSACCHARIDOSIS (MPS) TYPE 1 (HURLER) QUANTITATIVE, BLOOD, MUCOPOLYSACCHARIDOSIS (MPS) TYPE VI (MAROTEAUX LAMY) QUANTITATIVE, BLOOD, MYELIN ASSOCIATED GLYCOPROTEIN (MAG) IgM, MUCOPOLYSACCHARIDOSIS (MPS) TYPING, 24 HOUR URINE, MEASLES (RUBEOLA) ANTIBODIES PANEL IgG & IgM, MEDULLARY THYROID CARCINOMA MUTATION DETECTION, MYELIN ASSOCIATED GLYCOPROTEIN- SULFATED GLUCURONIC PARAGLOBOSIDE AUTOANTIBODY (MAG-SGPG) IgM, MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS; VAN DER KNAAP AND NALBAND MLC GENE HOTSPOT MUTATION, MALARIA PARASITE / BLOOD PARASITE IDENTIFICATION, MERRF (MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED RED FIBRES) MUTATION DETECTION, METACHROMATIC LEUCODYSTROPHY QUANTITATIVE, BLOOD, MYCOBACTERIUM TUBERCULOSIS PCR; MYCOSURE; TB PCR, MYCOBACTERIUM TUBERCULOSIS rRNA DETECTION, TMA, MYCOPLASMA PNEUMONIAE IgG & IgM ANTIBODIES PANEL, SERUM, METANEPHRINES FRACTIONATED, 24 HOUR URINE, MATERNAL BLOOD FOR FETAL DNA (MBFD) / NIPT, METANEPHRINES FRACTIONATED, RANDOM URINE, MYELOPEROXIDASE (MPO) STAIN, BLOOD / BONE MARROW, MYELOPROLIFERATIVE NEOPLASIA (MPN) EXTENDED PROFILE, MINIMAL RESIDUAL DISEASE (MRD) ANALYSIS FOR T-ALL, MYELOPROLIFERATIVE NEOPLASIA WITH EOSINOPHILIA, MINIMAL RESIDUAL DISEASE (MRD) ANALYSIS FOR B- ALL, MINIMAL RESIDUAL DISEASE (MRD) MONITORING FOR B-CLL, MINIMAL RESIDUAL DISEASE (MRD) MONITORING FOR MULTIPLE MYELOMA, MYOSITIS PROFILE EXTENDED IgG : 16 ANTIGENS, MITOCHONDRIAL ENCEPHALOMYOPATHY, LACTIC ACIDOSIS AND STROKE-LIKE EPISODES (MELAS) MUTATION DETECTION, MICM (MATERNALLY INHERITED CARDIOMYOPATHY) MUTATION DETECTION, MITOCHONDRIAL MUTATION DETECTION COMPREHENSIVE PANEL, MICROALBUMIN/ALBUMIN, 1ST MORNING / RANDOM URINE, MIXING STUDIES - APTT WITH PROTHROMBIN TIME STUDIES, MATERNAL SERUM SCREEN 2: ADVANCED REFLEX TO MATERNAL BLOOD FOR FETAL DNA (MBFD)/NIPT CHROMOSOME 21, MICROALBUMIN/ALBUMIN CREATININE RATIO, URINE, MMC (MATERNAL MYOPATHY WITH CARDIOMYOPATHY) MUTATION DETECTION, MATERNAL BLOOD FOR FETAL DNA (MBFD) / NIPT WITH MICRODELETIONS, MPL (MYELOPROLIFERATIVE LEUKEMIA) GENE MUTATION, MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION; MCHC, MTHFR (METHYLENE TETRAHYDROFOLATE REDUCTASE) GENE MUTATION, QUALITATIVE PCR, MITOCHONDRIAL ANTIBODY (AMA) IFA IN DILUTIONS, MUCOPOLYSACCHARIDOSIS (MPS) SCREEN, URINE, Nx GEN SEQUENCING: AMYOTROPHIC LATERAL SCLEROSIS, Nx GEN SEQUENCING: FAMILIAL HEMIPLEGIC MIGRAINE, Nx GEN SEQUENCING: COMPREHENSIVE EPILEPSY, NAFLD (NON ALCOHOLIC FATTY LIVER DISEASE) FIBROSIS SCORE, Nx GEN SEQUENCING: HEREDITARY RETINOBLASTOMA, Nx GEN SEQUENCING: LEBER CONGENITAL AMAUROSIS, NEURONAL (PARANEOPLASTIC) AUTOANTIBODIES PROFILE ULTRA, Nx GEN SEQUENCING: MEGALOENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS, NEURONAL (PARANEOPLASTIC) AUTOANTIBODIES PROFILE, NPM1 GENE MUTATION QUANTITATIVE MRD MONITOR, Nx GEN SEQUENCING: MICROPHTHALMIA / ANOPHTHALMIA / COLOBOMA SPECTRUM, NEURONAL (PARANEOPLASTIC) AUTOANTIBODIES PROFILE ADVANCED, NT-PRO BNP (N-TERMINAL PRO B TYPE NATRIURETIC PEPTIDE), NEUROVIRUSES COMPREHENSIVE PANEL QUALITATIVE PCR, NTx (COLLAGEN CROSS-LINKED N- TELOPEPTIDE), URINE, Nx GEN SEQUENCING: BETHLEM MYOPATHY, MYOFIBRILLAR MYOPATHY & ULLRICH MUSCULAR DYSTROPHY, Nx GEN CLINICAL EXOME SEQUENCING, ILLUMINA, Nx GEN CLINICAL EXOME SEQUENCING, THERMOFISHER, Nx GEN SEQUENCING: CHARCOT-MARIE-TOOTH DISEASE & SENSORY NEUROPATHIES, Nx GEN SEQUENCING: DRAVET'S SYNDROME & EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY, Nx GEN SEQUENCING: DUCHENNE & BECKER MUSCULAR DYSTROPHY, Nx GEN SEQUENCING: AICARDI-GOUTIERES SYNDROME, Nx Gen Sequencing:Tuberous sclerosis complex, NGAL (NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN), URINE, Nx GEN WHOLE EXOME SEQUENCING, THERMOFISHER, ONCOMINE ACUTE MYELOID LEUKAEMIA (AML) PANEL, OSMOTIC FRAGILITY TEST; RBC FRAGILITY TEST, ONCOMINE CHRONIC MYELOID LEUKAEMIA (CML) PANEL, ONCOMINE CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) PANEL, ONCOMINE JUVENILE MYELOMONOCYTIC LEUKEMIA (JMML) PANEL, ONCOMINE MYELODYSPLASTIC SYNDROME(MDS) PANEL, ONCOMINE MYELOPROLIFERATIVE NEOPLASM (MPN) PANEL, OPPORTUNISTIC ENTERIC PARASITE SCREEN, STOOL, ONCOPRO COMPREHENSIVE CANCER PANEL: 161 GENES, ONCOPRO FOCUS FUSION PANEL FOR SOLID TUMORS, P1NP (PROCOLLAGEN TYPE 1 AMINO TERMINAL PROPEPTIDE), TOTAL, PRE-ECLAMPSIA PREDICTOR (sFLT-1:PIGF RATIO) PANEL, PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1) ACTIVITY, PAN FUNGAL DETECTION AND IDENTIFICTION, PCR, PTHrP; PARATHYROID HORMONE RELATED PEPTIDE, PAPP-A (PREGNANCY ASSOCIATED PLASMA PROTEIN-A), PURKINJE CELL (Yo) ANTIBODY SCREEN, WITH REFLEX TO TITER AND WESTERN BLOT, CSF, PURKINJE CELL CYTOPLASMIC ANTIBODY TYPE Tr (DNER), PARIETAL CELL ANTIBODY, IFA IN DILUTIONS, PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH), CONFIRMATORY TEST, PARTIAL THROMBOPLASTIN TIME ACTIVATED; PTT; APTT, PARVOVIRUS B19 ANTIBODIES PANEL IgG & IgM, PIIINP (PROCOLLAGEN TYPE III AMINO TERMINAL PROPEPTIDE), PHOSPHATIDYLSERINE ANTIBODIES PANEL IgG & IgM, PLASMINOGEN ACTIVATOR INHIBITOR-1/SERPINE-1, 4G/5G GENOTYPING, PHOSPHOLIPASE A2 RECEPTOR ANTIBODY (PLA2R) QUALITATIVE, PHOSPHOLIPASE A2 RECEPTOR ANTIBODY (PLA2R) QUANTITATIVE, PML RARA t(15;17)(q22;q12) GENE REARRANGEMENT QUANTITATIVE PCR, PML RARA t(15;17)(q22;q12) GENE REARRANGEMENT QUALITATIVE PCR, PROTEIN ELECTROPHORESIS & IMMUNOTYPING, SERUM, PHOSPHOLIPID SYNDROME PANEL WITH BETA 2 GLYCOPROTEIN 1, IHR, PORPHYRINS TOTAL QUALITATIVE, RANDOM URINE, PORPHYRINS TOTAL QUANTITATIVE, 24- HOUR URINE, PML RARA t(15;17)(q22;q12) GENE REARRANGEMENT QUANTITATIVE MRD MONITOR, PORPHOBILINOGEN (PBG) QUANTITATIVE, 24 HOUR URINE, PCNA (PROLIFERATING CELL NUCLEAR ANTIGEN) ANTIBODY, PCOD (POLYCYSTIC OVARIAN DISEASE) COMPREHENSIVE PANEL, PRADER-WILLI SYNDROME MUTATION DETECTION METHYLATION SPECIFIC PCR, Q FEVER (COXIELLA BURNETTI) ANTIBODIES IgG & IgM, RESPIRATORY SYNCYTIAL VIRUS (RSV) ANTIGEN, ROCKY MOUNTAIN SPOTTED FEVER ANTIBODIES, ROMA; RISK OF OVARIAN MALIGNANCY ALGORITHM, RUBELLA (GERMAN MEASLES) ANTIBODIES PANEL IgG & IgM, RHEUMATOID AUTOIMMUNE COMPREHENSIVE PANEL, SALMONELLA TYPHI AND SALMONELLA PARATYPHI A ANTIGEN DETECTION, SOLUBLE TRANSFERRIN RECEPTOR (sTfR), SERUM, SPERM DNA FRAGMENTATION FLUORESCENT MICROSCOPY, Swasthfit Heart Check - Advance Health Checkup, SARS-COV-2 (COVID-19) RESPIRATORY COMPREHENSIVE PANEL, SCA-11 (SPINOCEREBELLAR ATAXIA): TTBK2 GENE MUTATION, SCA-12 (SPINOCEREBELLAR ATAXIA): PPP2R2B GENE MUTATION, SPINAL MUSCULAR ATROPHY (SMA) CARRIER DETECTION, SCA-17 (SPINOCEREBELLAR ATAXIA): TBP GENE MUTATION, SPINAL MUSCULAR ATROPHY (SMA) MUTATION DETECTION, Swasthfit Pro 3 (With Free Doctor Consultation), SCA-1 (SPINOCEREBELLAR ATAXIA): ATXN1 GENE MUTATION, SCA-2 (SPINOCEREBELLAR ATAXIA): ATXN2 GENE MUTATION, SCA (SPINOCEREBELLAR ATAXIA) PROFILE: ANY 4 MARKERS, SCA-3 (SPINOCEREBELLAR ATAXIA): ATXN3 GENE MUTATION, SCA-23 (SPINOCEREBELLAR ATAXIA): PDYN GENE MUTATION, SCA-5 (SPINOCEREBELLAR ATAXIA): SPTBN2 GENE MUTATION, SCA-14 (SPINOCEREBELLAR ATAXIA): PRKCG GENE MUTATION, SCA-6 (SPINOCEREBELLAR ATAXIA): CACNA1A GENE MUTATION, Swasthfit Total - Heart Check - Full Body Checkup, SCA-7 (SPINOCEREBELLAR ATAXIA): ATXN7 GENE MUTATION, Swasthfit Total - Iron Check - Full Body Checkup, SCA-8 (SPINOCEREBELLAR ATAXIA): ATXN8OS & ATXN8 GENE MUTATION, SCA (SPINOCEREBELLAR ATAXIA): COMPREHENSIVE PROFILE, SCRUB TYPHUS (TSUTSUGAMUSHI) IgM, RAPID ASSAY, STEROID PANEL: 21- HYDROXYLASE DEFICIENCY, Swasthfit Advance Health Checkup - Full Body Checkup, STEROID PANEL FOR CONGENITAL ADRENAL HYPERPLASIA (CAH), STEROID PANEL FOR PCOS / NON-CLASSICAL CAH DIFFERENTIATION, STEROID/ANDROGEN PROFILE FOR POLYCYSTIC OVARY SYNDROME (PCOS), STOOL EXAMINATION HANGING DROP PREPARATION, STOOL EXAMINATION pH & REDUCING SUBSTANCES, STREPTOCOCCUS GROUP B ANTIGEN DETECTION, SICKLE CELL ANEMIA TRIO PRENATAL MUTATION DETECTION, STRIATED / SKELETAL MUSCLE ANTIBODY(ASKA) IFA, Swasthfit Tax Saver Basic Health Checkup - Full Body Checkup, STRIATED / SKELETAL MUSCLE ANTIBODY(ASKA) IFA IN DILUTIONS, Swasthfit Tax Saver Advance Health Checkup - Full Body Checkup, SARS-CoV-2 (COVID-19) QUALITATIVE REAL TIME RT-PCR, SMOOTH MUSCLE ANTIBODY (ASMA) IFA IN DILUTIONS, SCA (SPINOCEREBELLAR ATAXIA): EXTENDED PROFILE, TPHA; TREPONEMA PALLIDUM HEMAGGLUTINATION, TPMT (THIOPURINE METHYL TRANSFERASE) GENOTYPING, TISSUE TRANSGLUTAMINASE (tTG) ANTIBODY IgG, TESTOSTERONE FREE & SEX HORMONE BINDING GLOBULIN, TB GOLD PLUS INTERFERON GAMMA RELEASE ASSAY (IGRA), TBII; THYROTROPIN - BINDING INHIBITORY IMMUNOGLOBULIN, TB LAMP (LOOP MEDIATED ISOTHERMA AMPLIFICATION) QUALITATIVE DNA PCR, MYCOBACTERIUM TUBERCULOSIS COMPLEX, TB PLATINUM INTERFERON GAMMA RELEASE ASSAY (IGRA), THALASSEMIA ALPHA TRIO PRENATAL MUTATION DETECTION, THALASSEMIA BETA TRIO PRENATAL MUTATION DETECTION, TSH STIMULATION BY TRH (THYROTROPIN RELEASING HORMONE), TSH (THYROID STIMULATING HORMONE) ULTRASENSITIVE, TSH (THYROID STIMULATING HORMONE) ULTRASENSITIVE, CORD BLOOD, TSI; THYROID STIMULATING IMMUNOGLOBULIN, TISSUE TRANSGLUTAMINASE (tTG) ANTIBODY IgA, TOTAL WBC COUNT & DIFFERENTAL COUNT & ESR, TYPHUS FEVER (RICKETTSIA) ANTIBODIES IgG & IgM, TB GOLD INTERFERON GAMMA RELEASE ASSAY (IGRA), t(1;19) (q23;p13.3); TCF3- BX1(E2A-PBX1) PCR QUALITATIVE, t(4;11) (q21;q23); (MLL-AF4) PCR QUALITATIVE, t(11;19) (q23;p13.3); (MLL-ENL) PCR QUALITATIVE, t(12;21) (p13;q22); ETV6-RUNX1 (TEL-AML1) PCR QUALITATIVE, t(9;11) (p21-22;q23); (MLL-AF9) PCR QUALITATIVE, URINE EXAMINATION ROUTINE; URINE R/E AUTOMATED, UGT1A1 GENE POLYMORPHISM (NUCLEOTIDE 'TA' REPEATS) DETECTION, VITAMIN B1 (THIAMINE PYROPHOSPHATE), BLOOD, VANCOMYCIN RESISTANT ENTEROCOCCI (VRE) SCREENING, VITAMIN B12 BINDING CAPACITY UNSATURATED; TRANSCOBALAMIN, VARICELLA ZOSTER VIRUS (VZV) QUALITATIVE PCR, VMA (VANILLYL MANDELIC ACID), 24 HOUR URINE, VMA (VANILLYL MANDELIC ACID), RANDOM URINE, VON WILLEBRAND FACTOR COLLAGEN BINDING ACTIVITY (vWF:CB), VGKC (VOLTAGE GATED POTASSIUM CHANNEL) ANTIBODY, SERUM, VON WILLEBRAND FACTOR RISTOCETIN COFACTOR ACTIVITY (vWF:RCo), VGKC (VOLTAGE GATED POTASSIUM CHANNEL) ANTIBODY, CSF, VARICELLA ZOSTER VIRUS (VZV) ANTIBODIES PANEL IgG & IgM, VARICELLA ZOSTER VIRUS (VZV) ANTIBODY IgG, VARICELLA ZOSTER VIRUS (VZV) ANTIBODY IgM, von WILLEBRAND FACTOR ANTIGEN; vWF Ag, WILSON DISEASE ATP7 B GENE MUTATION DETECTION, XPERT XPRESS SARS-CoV-2 (COVID-19) QUALITATIVE, Y-CHROMOSOME MICRODELETION DETECTION , PCR, YEAST (CANDIDA SPECIES) SUSCEPTIBILITY TESTING.

Thug Kitchen Banh Mi, Goblin Shaman 5e, Amherst College Employment Verification, 1 Peter 3 Msg, Aim And Scope Of Biochemistry, Silver Stem Fraser, Domino's Pan Pizza Review, How To Be A Good Administrator At Office,

No intelligent comments yet. Please leave one of your own!

Leave a Reply